Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder

Clinical trial NCT00088465 · COMPLETED

Trial details

NCT number: NCT00088465
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Schizophrenic Disorders Schizoaffective Disorder

Start date: 2004-08-01
Primary completion: 2010-12-01
Enrollment: 931

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.